EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study

Luciano Ibba, Sara Di Giulio, Piergiorgio Malagoli, Anna Balato, Federico Bardazzi, Massimo Travaglini, Giampiero Girolomoni, Martina Maurelli, Martina Burlando, Stefano Caccavale, Carlo G Carrera, Andrea Carugno und 18 weitere

Dermatology and Therapy · 2026-08 · 16 (8) · 3961-3977

DOI: 10.1007/s13555-026-01797-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology and Therapy, online erschienen am 09.06.2026. Verfasst von Luciano Ibba und 29 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Anti-IL17BiologicsPsoriasisReal-LifeSecukinumab

Autor:innen und Institutionen

  • Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.
  • Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy.
  • Dermatology Unit, University of Campania L. Vanvitelli, Naples, Italy.
  • Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

Zitieren

APA

Ibba, L., Di Giulio, S., Malagoli, P., Balato, A., Bardazzi, F., Travaglini, M., Girolomoni, G., Maurelli, M., Burlando, M., Caccavale, S., Carrera, C. G., Carugno, A., Dapavo, P., Di Brizzi, E. V., Dini, V., Gaiani, F. M., Guarneri, C., Lasagni, C., Loconsole, F., …, & Valenti, M. (2026). Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study. Dermatology and Therapy, 16(8), 3961-3977. https://doi.org/10.1007/s13555-026-01797-9

Vancouver

Ibba L, Di Giulio S, Malagoli P, Balato A, Bardazzi F, Travaglini M, et al. Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study. Dermatology and Therapy. 2026;16(8):3961-3977. doi:10.1007/s13555-026-01797-9

BibTeX
@article{Ibba2026,
  author = {Ibba, Luciano and Di Giulio, Sara and Malagoli, Piergiorgio and Balato, Anna and Bardazzi, Federico and Travaglini, Massimo and Girolomoni, Giampiero and Maurelli, Martina and Burlando, Martina and Caccavale, Stefano and Carrera, Carlo G and Carugno, Andrea and Dapavo, Paolo and Di Brizzi, Eugenia V and Dini, Valentina and Gaiani, Francesca M and Guarneri, Claudio and Lasagni, Claudia and Loconsole, Francesco and Marzano, Angelo V and Megna, Matteo and Michelucci, Alessandra and Potestio, Luca and Ribero, Simone and Sacchelli, Lidia and Zerbinati, Nicola and Mastorino, Luca and Costanzo, Antonio and Narcisi, Alessandra and Valenti, Mario},
  title = {Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study},
  journal = {Dermatology and Therapy},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {3961--3977},
  doi = {10.1007/s13555-026-01797-9}
}
Kostenlos starten →